Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Im +40 lbs down and counting
doi: 10.1016/S0140-6736(18)32260-8
This personalization capacity supports better adherence and adverse-effect management compared to one-size-fits-all branded protocols
Research Applications Obesity and severe obesity treatment research Type 2 diabetes management studies Metabolic syndrome and cardiometabolic disease research Metabolic dysfunction-associated steatohepatitis (MASH) studies Triple incretin/glucagon receptor agonist research Energy expenditure and thermogenesis studies Hepatic fat metabolism and NAFLD research Body composition and weight loss research Cardiovascular risk reduction studies Multi-agonist peptide therapeutic research Appetite regulation and satiety research Glucose homeostasis and insulin sensitivity studies Safety Profile Retatrutide is currently in late-stage clinical development with ongoing safety evaluation through comprehensive Phase 3 trials, but existing Phase 1 and Phase 2 data provide substantial information about its safety profile
2020;105(8):e2710e2716
Diabetes Care 39 , 23042310 (2016)
